Mark Mann

Canadian researcher demonstrates experimental drug's potency against COVID-19

Mark Mann
April 15, 2020

In a recent paper, University of Alberta researcher Dr. Matthias Gotte has shown that the drug remdesivir — developed by Gilead Sciences to treat Ebola in 2014 — is highly effective at stopping SARS-CoV-2 from replicating.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics
People: Dr. Matthias Gotte

Other News

The Short Report, April 8, 2020: Mitacs steps up to help SMEs working on COVID-19 solutions; StatCan partners on ambitious business conditions survey; and more

VIDO-InterVac in Saskatchewan fielding massive demand for testing of COVID-19 vaccines and therapeutics

UPDATE: Incoming McGill research director withdraws after backlash for past charges of discrimination

CIHR cancels flagship funding program to focus on COVID-19 response






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.